Evaluation of Clinicopathological Factors in Patients with Resected Stage I-IIIA Breast Cancer (N-SAS-BC 01/CUBC Biomarker Study)
Not Applicable
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000022571
- Lead Sponsor
- SRL Medisearch Inc.
- Brief Summary
HR+/HER2-: 10yr RFS CMF:81.2% UFT:76.7% 10yr OS CMF:89.5% UFT:91.0% HR-/HER2-: 10yr RFS CMF:84.7% UFT:78.2% 10yr OS CMF:89.4% UFT:84.6% HR+/HER2+: 10yr RFS CMF:73.7% UFT:71.4% 10yr OS CMF:68.4% UFT:81.2% HR-/HER2+: 10yr RFS CMF:73.7% UFT:71.4% 10yr OS CMF:78.9% UFT:90.9%
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 707
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients judged by their physician to be unfit to participate in this study 2) Patients who declined to consent to research use of their samples
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relapse free survival
- Secondary Outcome Measures
Name Time Method Overall survival